Selenite is a potent cytotoxic agent for human primary AML cells.
暂无分享,去创建一个
S. Lehmann | A. Fernandes | Inmaculada Ribera‐Cortada | M. Björnstedt | L. Eriksson | C. Paul | Eric Olm | A. Rundlöf | Kerstin Jönsson-Videsäter
[1] Kum Kum Khanna,et al. From selenium to selenoproteins: synthesis, identity, and their role in human health. , 2007, Antioxidants & redox signaling.
[2] B. Berk,et al. Glutathiolation Regulates Tumor Necrosis Factor-&agr;–Induced Caspase-3 Cleavage and Apoptosis: Key Role for Glutaredoxin in the Death Pathway , 2007, Circulation research.
[3] G. Nilsonne,et al. Quantification of alternative mRNA species and identification of thioredoxin reductase 1 isoforms in human tumor cells. , 2007, Differentiation; research in biological diversity.
[4] R. Zhao,et al. Apoptosis induced by selenomethionine and methioninase is superoxide mediated and p53 dependent in human prostate cancer cells , 2006, Molecular Cancer Therapeutics.
[5] K. Becker,et al. On the potential of thioredoxin reductase inhibitors for cancer therapy. , 2006, Seminars in cancer biology.
[6] G. Nilsonne,et al. Selenite induces apoptosis in sarcomatoid malignant mesothelioma cells through oxidative stress. , 2006, Free radical biology & medicine.
[7] K. Khanna,et al. The Redox State of SECIS Binding Protein 2 Controls Its Localization and Selenocysteine Incorporation Function , 2006, Molecular and Cellular Biology.
[8] P. Nguyen,et al. Thioredoxin reductase as a novel molecular target for cancer therapy. , 2006, Cancer letters.
[9] A. Burnett,et al. Treatment of older patients with acute myeloid leukemia--new agents. , 2006, Seminars in hematology.
[10] R. Zhao,et al. Expression of p53 enhances selenite-induced superoxide production and apoptosis in human prostate cancer cells. , 2006, Cancer research.
[11] D. Peehl,et al. Tumor‐selective killing by selenite in patient‐matched pairs of normal and malignant prostate cells , 2006, The Prostate.
[12] W. Korohoda,et al. Differential effects of selenite and selenate on human melanocytes, keratinocytes, and melanoma cells. , 2005, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[13] S. Orrenius,et al. Overexpression of glutaredoxin 2 attenuates apoptosis by preventing cytochrome c release. , 2005, Biochemical and biophysical research communications.
[14] Jian Li,et al. Sodium selenite induces apoptosis in acute promyelocytic leukemia-derived NB4 cells by a caspase-3-dependent mechanism and a redox pathway different from that of arsenic trioxide , 2004, Annals of Hematology.
[15] V. Gladyshev,et al. Alternative splicing involving the thioredoxin reductase module in mammals: a glutaredoxin-containing thioredoxin reductase 1. , 2004, Biochemistry.
[16] J. Gustafsson,et al. An Alternative Splicing Variant of the Selenoprotein Thioredoxin Reductase Is a Modulator of Estrogen Signaling* , 2004, Journal of Biological Chemistry.
[17] Elias S. J. Arnér,et al. Regulation of the mammalian selenoprotein thioredoxin reductase 1 in relation to cellular phenotype, growth, and signaling events. , 2004, Antioxidants & redox signaling.
[18] A. Holmgren,et al. Glutaredoxins: glutathione-dependent redox enzymes with functions far beyond a simple thioredoxin backup system. , 2004, Antioxidants & redox signaling.
[19] E. Larsen,et al. Selenium prevents tumor development in a rat model for chemical carcinogenesis. , 2004, Carcinogenesis.
[20] Elias S. J. Arnér,et al. Evidence for intriguingly complex transcription of human thioredoxin reductase 1. , 2004, Free radical biology & medicine.
[21] A. Rosén,et al. Selenite-induced apoptosis in doxorubicin-resistant cells and effects on the thioredoxin system. , 2004, Biochemical pharmacology.
[22] K. Becker,et al. The thioredoxin system—From science to clinic , 2004, Medicinal research reviews.
[23] S. Lehmann,et al. Drug-resistant human lung cancer cells are more sensitive to selenium cytotoxicity. Effects on thioredoxin reductase and glutathione reductase. , 2002, Biochemical pharmacology.
[24] P. Caffrey,et al. A prevention strategy for circumventing drug resistance in cancer chemotherapy. , 2001, Current pharmaceutical design.
[25] V. Gladyshev,et al. Selenoprotein oxidoreductase with specificity for thioredoxin and glutathione systems , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[26] Elias S. J. Arnér,et al. Physiological functions of thioredoxin and thioredoxin reductase. , 2000, European journal of biochemistry.
[27] M. Rayman,et al. The importance of selenium to human health , 2000, The Lancet.
[28] A. Holmgren,et al. Essential Role of Selenium in the Catalytic Activities of Mammalian Thioredoxin Reductase Revealed by Characterization of Recombinant Enzymes with Selenocysteine Mutations* , 2000, The Journal of Biological Chemistry.
[29] J. Gustafsson,et al. Human mitochondrial thioredoxin reductase cDNA cloning, expression and genomic organization. , 1999, European journal of biochemistry.
[30] S. Rhee,et al. Molecular Cloning and Characterization of a Mitochondrial Selenocysteine-containing Thioredoxin Reductase from Rat Liver* , 1999, The Journal of Biological Chemistry.
[31] P. Caffrey,et al. Treatment of human ovarian tumor xenografts with selenite prevents the melphalan-induced development of drug resistance. , 1998, Anticancer research.
[32] E. Constant,et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. , 1998 .
[33] G. Powis,et al. Cellular thioredoxin reductase activity is regulated by selenium. , 1997, Anticancer research.
[34] A. Holmgren,et al. Selenium and the thioredoxin and glutaredoxin systems. , 1997, Biomedical and environmental sciences : BES.
[35] M. Slovak,et al. Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study. , 1997, Blood.
[36] Bruce W. Turnbull,et al. Effects of Selenium Supplementation for Cancer Prevention in Patients With Carcinoma of the Skin: A Randomized Controlled Trial , 1996 .
[37] A. Holmgren,et al. Selenite and selenate inhibit human lymphocyte growth via different mechanisms. , 1996, Cancer research.
[38] Y. Park,et al. Metabolism of subtoxic levels of selenium in animals and humans. , 1996, Annals of clinical and laboratory science.
[39] I. Cree,et al. Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplatin resistance of ovarian carcinoma. , 1995, Cancer research.
[40] A. Holmgren,et al. Selenite is a substrate for calf thymus thioredoxin reductase and thioredoxin and elicits a large non-stoichiometric oxidation of NADPH in the presence of oxygen. , 1992, European journal of biochemistry.
[41] A. Holmgren,et al. Selenodiglutathione is a highly efficient oxidant of reduced thioredoxin and a substrate for mammalian thioredoxin reductase. , 1992, The Journal of biological chemistry.
[42] X. Li,et al. Studies of safe maximal daily dietary selenium intake in a seleniferous area in China. I. Selenium intake and tissue selenium levels of the inhabitants. , 1989, Journal of trace elements and electrolytes in health and disease.
[43] A. Holmgren. Bovine thioredoxin system. Purification of thioredoxin reductase from calf liver and thymus and studies of its function in disulfide reduction. , 1977, The Journal of biological chemistry.
[44] A. Jemal,et al. Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.
[45] Wen Li,et al. Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong , 2007, Biological Trace Element Research.
[46] B. Lipiński,et al. Rationale for the treatment of cancer with sodium selenite. , 2005, Medical hypotheses.
[47] J. Liliemark,et al. Intracellular concentrations of anti cancer drugs in leukemic cells in vitro vs in vivo , 2004, Cancer Chemotherapy and Pharmacology.
[48] T. Shen,et al. Induction of apoptosis by sodium selenite in human acute promyelocytic leukemia NB4 cells: involvement of oxidative stress and mitochondria. , 2003, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.
[49] R. Snyder. Effects of sodium selenite on DNA and carcinogen-induced DNA repair in human diploid fibroblasts. , 1987, Cancer letters.
[50] L. Kangas,et al. Bioluminescence of cellular ATP: a new method for evaluating cytotoxic agents in vitro. , 1984, Medical biology.
[51] A. Weisberger,et al. Studies on analogues of L-cysteine and L-cystine. III. The effect of selenium cystine on leukemia. , 1956, Blood.